Telemedicine use in neonatal follow-up programs - What can we do and what we can't - Lessons learned from COVID-19.
Semin Perinatol
; 45(5): 151430, 2021 08.
Article
in English
| MEDLINE | ID: covidwho-1203278
ABSTRACT
Little empirical data support the use of telemedicine to provide medical and developmental follow-up care to preterm and high-risk infants after hospital discharge. Nevertheless, the COVID-19 pandemic temporarily rendered telemedicine the only means by which to provide essential follow-up care to this population. In this article we discuss our institution's experience with rapid implementation of telemedicine in a multi-site neonatal follow-up program as well as benefits and limitations of the use of telemedicine in this context. Finally, we discuss the current problems that must be solved in order to optimize telemedicine as a tool for providing comprehensive, multidisciplinary medical and developmental care to high risk infants and their families.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Patient Care Team
/
Telemedicine
/
Aftercare
/
COVID-19
/
Infant Care
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Limits:
Humans
/
Infant, Newborn
Country/Region as subject:
North America
Language:
English
Journal:
Semin Perinatol
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS